Charles A. McKesson
Co-founder 1833Background
Charles A. McKesson co-founded Olcott & McKesson in 1833 with the radical vision of importing and wholesaling high-quality botanical drugs and chemicals to the burgeoning American medical market, a decision that shifted the company away from the traditional methods of drug discovery and established the foundational business model of scalable, reliable physical distribution.
Role at McKesson Corporation
McKesson possesses a rooted, historical founding story, tracing its origins directly back to the incredible economic explosion of the 19th-century American maritime trade and the lucrative, unregulated early days of botanical medicines. The company was founded in 1833 in the bustling seaport of New York City by John McKesson and Charles Olcott. At the time, modern synthetic pharmaceuticals did not exist. The healthcare industry relied almost entirely on raw botanical roots, exotic herbs, and essential oils imported via clipper ships from Europe and Asia. John McKesson was an ambitious, meticulous young clerk, and Charles Olcott was an experienced local merchant. They pooled their limited capital and founded 'Olcott & McKesson' specifically to dominate the lucrative import of these raw therapeutic botanicals. Their foundational masterstroke was an obsession with quality control. In an era when heavily adulterated, toxic 'snake oil' remedies were rampant, they heavily invested in strict laboratory testing, guaranteeing the purity of their imported ingredients to local apothecaries. In 1853, following Olcott's death, Daniel Robbins (who had started as an apprentice in the firm) was made a partner, and the firm was renamed McKesson & Robbins. They executed an aggressive, strategy of westward expansion, pioneering the complex logistics of shipping fragile glass bottles of medicine across the entire continent on the newly built transcontinental railroads. By establishing reliable, scaled distribution networks for early medicine, John McKesson built the foundational architecture that still underpins the modern American pharmaceutical supply chain today.